Browsing publications by Dr Mark Hudson

Newcastle AuthorsTitleYearFull text
Dr David Crossland
Dr Mark Hudson
Fontan-associated liver disease: Implications for heart transplantation2016
Dr James Orr
Dr Mark Hudson
Editorial: prolonged remission from hepatic encephalopathy with rifaximin2015
Dr Jessica Dyson
Dr Ahmed Elsharkawy
Dr Chris Lamb
Dr Ahmad Al-Rifai
Professor Julia Newton
et al.
Fatigue in primary sclerosing cholangitis is associated with sympathetic over-activity and increased cardiac output2015
Dr Jessica Dyson
Dr Chris Lamb
Dr Mark Hudson
Dr Stuart McPherson
Implementation and impact of a care bundle for the management of patients with decompensated liver disease2015
Dr Jessie Dyson
Dr Mark Hudson
Implementation of the Lancet Standing Commission on Liver Disease in the UK2015
Dr James Orr
Dr Mark Hudson
The impact on hospital resource utilisation of Rifaximin-alpha for hepatic encephalopathy in routine clinical practice: Real world data from seven UK liver centres2015
Dr Mark Hudson
UK guidelines on the management of variceal haemorrhage in cirrhotic patients2015
Stuart Robinson
Dr Steven Masson
Dr Mark Hudson
Professor Derek Manas
Umbilical hernia repair in cirrhosis: outcomes and prognostic factors in a liver transplant unit2015
Dr Jessica Dyson
Dr Mark Hudson
Professor Derek Manas
Dr Steven Masson
A Positive Complement Dependent Cytotoxic (CDC) Crossmatch Does Not Impact on Patient Survival or Increase the Risk of Acute Cellular Rejection, or Biliary Strictures after Liver Transplantation2014
Dr Mark Hudson
Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis2014
1234567891011